112285 ⎘
Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
COMPOSITIONS AND SYSTMES FOR HERPES SIMPLEX VIRUS PACKAGING AND USES THEREOF
#2LIPID NANOPARTICLES FOR BIOPRODUCTION
#3ADENO-ASSOCIATED VIRUS (AAV) PRODUCER CELL LINES
#4Genome Engineering
#5DOXYCYCLINE INDUCIBLE EXPRESSION SYSTEM
#6TUMOR ENVIRONMENT-SPECIFIC EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS
#7PLASMIDS AND METHODS OF PRODUCTION OF ADENO-ASSOCIATED VIRUSES
#8ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE
#9EXPRESSION VECTORS COMPOSITION
#10Producer Cell Having Low Levels of VA-RNA
#11CTA VACCINE CASSETTES
#12PHOSPHATE SENSING MICROBIAL GENE SWITCH
#13VIRUS-LIKE PARTICLE STABLY EXPRESSED BY ANIMAL CELLS AS VACCINE ANTIGEN AGAINST COVID-19 AND INFLUENZA VIRUS
#14MULTIPLEX ASSAY
#15VERO CELL LINES STABLY EXPRESSING HSV ICP0 PROTEIN
#16EFFICIENT SYSTEM FOR PRODUCING ADENO-ASSOCIATED VIRUS (AAV) VECTOR
#17REPROGRAMMING OF SOMATIC CELLS
#18ADENO-ASSOCIATED VIRUS (AAV) PRODUCER CELL LINES
#19An Immunogenic Composition of Disease-Associated Antigens for Use in a Vaccine, Antibody Production and Immunodiagnostic Tests
#20Controllable Transcription
#21TEMPERATURE-INDUCIBLE EXPRESSION SYSTEM FOR THERMOPHILIC ORGANISMS
#22Method for screening a signal peptide for efficient expression and secretion of a heterologous polypeptide in mammalian cells
#23STABLE PRODUCTION SYSTEMS FOR AAV VECTOR PRODUCTION
#24SALMONELLA STRAIN FOR PREVENTION AND TREATMENT OF CANCER AND USE THEREOF
#25OPTIMIZED CYP4V2 GENE AND APPLICATION THEREOF
#26COMPOSITIONS AND METHODS FOR THE GENERATION OF NEURONS AND USES THEREOF
#27Genetically Engineered Phagocytes, and Related Compositions, Vectors, Methods and Systems
#28Multi-Genome Editor Construct and Uses Thereof
#29METHODS FOR REPROGRAMMING SOMATIC CELLS
#30Controllable Transcription
#31BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL
#32STABLE PRODUCTION SYSTEMS FOR LENTIVIRAL VECTOR PRODUCTION
#33HSV AMPLICON PACKAGING SYSTEM USING ENGINEERED CELLS
#34METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS WITH BCL11A TRANSCRIPTION FACTOR EXPRESSION
#35GENE THERAPY FOR RETINAL DISEASES
#36SELF-LIMITING, SEX-SPECIFIC GENE AND METHODS OF USING
#37VIRAL VECTORS AND NUCLEIC ACIDS FOR REGULATED GENE THERAPY
#38TRANSPOSON-BASED VECTORS AND USES
#39Controllable Transcription
#40Controllable Transcription
#41CHIMERIC ANTIGEN RECEPTOR EXPRESSION SYSTEMS
#42TETRACYCLINE-INDUCIBLE EXPRESSION SYSTEM
#43DETECTION OF GENE LOCI WITH POLYCHROMATIC CRISPR-ASSOCIATED PROTEIN 9
#44ACTIVATION OF LYTIC GENES IN CANCER CELLS
#45METHODS FOR SCREENING VARIANT OF TARGET GENE
#46DIRECT REPROGRAMMING OF SOMATIC CELLS INTO MYOGENIC CELLS
#47CONDITIONALLY REPLICATING M. BOVIS BCG
#48Methods for reprogramming somatic cells
#49Co-regulatory sequences based on tetracycline and Cumate
#50Tetracycline-inducible expression systems
#51Genome Engineering
#52DNA Construct for Diagnosing and Treating Cancer
#53RAPID AND DETERMINISTIC GENERATION OF MICROGLIA FROM HUMAN PLURIPOTENT STEM CELLS
#54Inducible expression from transposon-based vectors and uses
#55Lentivirus packaging system comprising a synthetic positive feedback loop
#56Methods of Cell Renewal
#57Targeting Vector, Nucleic Acid Composition, and Method for Constructing Liver-injured Mouse Model
#58NOVEL REPROGRAMMING METHOD
#59Methods and systems for generating complex spatial patterns
#60COMPOSITIONS AND METHODS UTILIZING GENETICALLY-MODIFIED ANIMALS AND CELLS
#61MUTANT REVERSE TETRACYCLINE TRANSACTIVATORS FOR EXPRESSION OF GENES
#62Expression vector and method
#63Expression from transposon-based vectors and uses
#64Method for Obtaining Haploid Cells
#65Compositions and Methods for Enhancement of Homology-Directed Repair Mediated Precise Gene Editing by Programming DNA Repair with a Single RNA-Guided Endonuclease
#66TUMOR ENVIRONMENT-SPECIFIC EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS
#67Methods and compositions for inducible expression of neurotrophic factors
#68Methods for screening variant of target gene
#69Self-limiting, sex-specific gene and methods of using
#70Methods for screening variant of target gene
#71Methods for reprogramming somatic cells
#72LENT-ON-PLUS SYSTEM FOR CONDITIONAL EXPRESSION IN HUMAN STEM CELLS
#73STEM CELL DELIVERED ONCOLYTIC HERPES SIMPLEX VIRUS AND METHODS FOR TREATING BRAIN TUMORS
#74Vero cell lines stably expressing HSV ICP0 protein
#75Stable cell lines for retroviral production
#76Engineered Cellular Pathways for Programmed Autoregulation of Differentiation
#77CONDITIONALLY IMMORTALIZED CELLS AND METHODS FOR THEIR PREPARATION
#78Method of treating type I diabetes using an AAV vector encoding uracortin 2
#79METHODS FOR CREATING SYNTHETIC CHROMOSOMES HAVING GENE REGULATORY SYSTEMS AND USES THEREOF
#80Controllable transcription
#81ORTHOGONAL TRANSCRIPTIONAL SWITCHES DERIVED FROM TET REPRESSOR HOMOLOGS FOR SACCHAROMYCES CEREVISIAE
#82Detection of gene loci with CRISPR arrayed repeats and/or polychromatic single guide ribonucleic acids
#83Inducible expression from transposon-based vectors and uses
#84Expression from transposon-based vectors and uses
#85AMPLIFIED PRODUCTION OF MONOCLONAL ANTIBODIES
#86Lentivirus packaging system comprising a synthetic positive feedback loop
#87Vaccine against beta-herpesvirus infection and use thereof
#88Methods for reprogramming somatic cells
#89Hybrid promoter and uses thereof
#90Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#91LENTIVIRAL VECTORS AND USES THEREOF
#92Gene expression system using alternative splicing in insects
#93Method for expression of small RNA molecules within a cell
#94Methods of cell renewal
#95Method of treating type I diabetes using an AAV vector encoding uracortin 2
#96In vivo methods for identifying cancer-associated immunotherapy targets
#97Reprogramming of somatic cells
#98Methods and Vectors to Produce Vector Free Induced Pluripotent Stem Cells
#99Expression cassette and vector comprising Alzheimer's disease-related mutant genes and cell line transformed by means of same
#100Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#101Engineered Cellular Pathways for Programmed Autoregulation of Differentiation
#102Activity-dependent expression of nucleic acids
#103Genome engineering
#104Method of obtaining transformed plant cell
#105Dosage compensating transgenes and cells
#106Gene expression system using alternative splicing in insects
#107Methods for reprogramming somatic cells
#108Insulator to improve gene transfer vectors
#109Vector construct with human hypoxia inducible factor α gene
#110Amyloid beta expression constructs and uses therefor
#111Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#112Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using
#113Vector for the selective silencing of a gene in astrocytes
#114Method for expression of small RNA molecules within a cell
#115Reprogramming of somatic cells
#116Genome engineering
#117Genome engineering
#118Methods and compositions for producing induced airway tissue progenitor cells
#119RbAp48 transgenic mice for drug discovery in age-related memory decline
#120Engineered cellular pathways for programmed autoregulation of differentiation
#121Human erythroid progenitor cell line comprising HPV E6/E7 operably linked to an inducible promoter and method for producing human enucleated red blood cells
#122Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#123Vaccine against beta-herpesvirus infection and use thereof
#124Methods for reprogramming somatic cells
#125Compositions for identifying reprogramming factors
#126Methods for reprogramming somatic cells
#127Methods for reprogramming somatic cells
#128In vivo gene regulation by the combination of knock-in-tetO sequence into the genome and tetracycline-controlled trans-suppressor (tTS) protein
#129PHARMACOLOGICALLY INDUCED TRANSGENE ABLATION SYSTEM
#130Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancers
#131Herpes simplex virus vaccines
#132REGULATED EXPRESSION SYSTEMS
#133Diagnosis of depression
#134Methods for producing microRNAs
#135Pharmacologically induced transgene ablation system
#136METHODS OF EXPRESSING A POLYPEPTIDE IN THE BRAIN AND NUCLEIC ACID CONSTRUCTS CAPABLE OF SAME
#137Methods and compositions for treating neuropathic and neurodegenerative conditions
#138Tetracycline inducible transcription control sequence
#139Senescene Cells and Methods For Its Production
#140Compositions and Systems for the Regulation of Genes
#141Reprogramming of somatic cells
#142SELF-INACTIVATING HELPER ADENOVIRUSES FOR THE PRODUCTION OF HIGH-CAPACTIY RECOMBINANT ADENOVIRUSES
#143MAO-B ELEVATION AS AN EARLY PARKINSON'S DISEASE BIOMARKER
#144VECTORS AND METHODS FOR GENERATING VECTOR-FREE INDUCED PLURIPOTENT STEM (IPS) CELLS USING SITE-SPECIFIC RECOMBINATION
#145Method for expression of small RNA molecules within a cell
#146Controlled activation of non-LTR retrotransposons in mammals
#147Antibody-producing transgenic silkworms and methods for producing the same
#148VIRAL VECTOR SYSTEM, A COMPOSITION COMPRISING THE VIRAL VECTOR SYSTEM AND ITS USE
#149Engineered cellular pathways for programmed autoregulation of differentiation
#150Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#151Methods and compositions for treating neuropathic and neurodegenerative conditions
#152Method for increasing cardiac mass and performance
#153Compositions for reprogramming somatic cells
#154ATTENUATED INVASIVE E.COLI STRAINS AND APPLICATIONS THEREOF AS INTRACELLULAR VECTOR FOR THERAPEUTIC MOLECULE
#155Inducible fluorescently-tagged protein expression system
#156Novel therapeutic and diagnostic products and methods
#157Fluorescent mouse model
#158Methods for making somatic cells more susceptible to reprogramming
#159Method for transcription/degradation dual control of protein by antibiotic
#160Hepatitis C virus vaccine
#161Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression
#162METHODS AND REAGENTS FOR SCREENING NEW DRUGS AND FOR TREATING ION PUMP ASSOCIATED DISORDERS AND DISEASES
#163INDUCIBLE LENTIVIRAL VECTORS FOR REPROGRAMMING SOMATIC CELLS
#164Transgenic non-human animal models of apoptosis-mediated conditions
#165Inducible expression systems
#166Serotype of adenovirus and uses thereof
#167Tetracycline repressor regulated oncolytic viruses
#168PANCREATIC ENDOCRINE PROGENITOR CELLS DERIVED FROM PLURIPOTENT STEM CELLS
#169METHODS OF REGULATING EXPRESSION OF GENES OR OF GENE PRODUCTS USING SUBSTITUTED TETRACYCLINE COMPOUNDS
#170Hepatitis C virus vaccine
#171Compositions and Methods Related to Controlled Gene Expression Using Viral Vectors
#172Use of the ornithine transcarbamylase (), as a marker for diagnosing brain damages
#173Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome formation
#174Methods for producing microRNAs
#175TRANSGENIC ORGANISM
#176Sex-specific regulation of aging and apoptosis
#177Methods for reprogramming somatic cells
#178Genetic manipulation method
#179Method and means for producing high titer, safe, recombinant lentivirus vectors
#180Administration of transposon-based vectors to reproductive organs
#181Gene regulation in transgenic animals using a transposon-based vector
#182Vectors and Methods Using Same
#183Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors
#184In vivo amplification of neural progenitor cells
#185Method for producing transgenic rats
#186Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
#187Tetracycline repressor regulated oncolytic viruses
#188Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#189Method for expression of small antiviral RNA molecules within a cell
#190Chimeric cancer models
#191Means and methods for producing a stabilized cell of interest
#192Platelet bioreactor
#193Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
#194Transgenic mouse capable of over-expressing VE-PTP
#195Conditional gene vectors regulated in
#196Autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells
#197Reconstituted human breast tumor model
#198Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
#199Production of human glycosylated proteins in transgenic insects
#200Methods for producing microRNAs
#201Methods for treating demyelination disorders
#202Inducible plasmid vector encoding TGF-β and use thereof
#203Mutants of replication competent vaccinia virus
#204Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
#205Methods and compositions for modulating angiogenesis
#206Expression system for stem-loop rna molecule having rnai effect
#207Increasing gamete production with a gene switch
#208Chimeric viral vectors for gene therapy
#209Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
#210Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
#211Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
#212Lentiviral vectors and uses thereof
#213Promiscuous G-protein compositions and their use
#214Transgenic cell and gene recombinant animal having a mutant SDHC gene derived from mammals
#215Methods and compositions for treating neuropathic and neurodegenerative conditions
#216Gene regulation with aptamer and modulator complexes for gene therapy
#217Genetic inhibition of epidermal growth factor receptor function and carcinoma cell radiosensitization
#218Serotype of adenovirus and uses thereof
#219Method of screening a midkine modulating agent
#220Regulatable promoters for synthesis of small hairpin RNA
#221Dna vaccine
#222Methods and compositions for generating homozygous mutations
#223Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
#224Viral vector
#225SiRNA mediated gene silencing in transgenic animals
#226Transgenic mice generated by transposition and uses thereof
#227Vectors and methods for the mutagenesis of mammalian genes
#228Compositions and systems for the regulation of genes
#229Pseudotyped lentiviral vectors and uses thereof